Background. Human herpesvirus 8 (HHV8), the infectious cause of Kaposi sarcoma, varies dramatically across Africa, suggesting that cofactors correlated with large-area geographic or environmental characteristics may influence risk of infection. Variation in HHV8 seropositivity across small-area regions within countries in Africa is unknown. We investigated this issue in Uganda, where Kaposi sarcoma distribution is uneven and well described.
are high in Eastern and Central Africa but are comparatively low in Western, Northern, and Southern Africa [2, 3] . The geographic gradient of HHV8 seropositivity and KS incidence has prompted several authors to postulate that geographic or environmental cofactors, including volcanic soils [4] , plants [5] , and itchy insect bites [6] , may influence the transmission of HHV8 and/or the progression to KS, given HHV8 infection. The HHV8-KS geographic correlation, however, is imperfect because high HHV8 seropositivity coupled with low KS incidence has been reported in some countries, such as Botswana [7] and The Gambia [8] . This imperfect correlation between HHV8 seropositivity and KS suggests that the effects of geographic or environmental exposures may influence both HHV8 infection and progression to KS, given HHV8 infection, whereas others may influence only 1 of the processes. Current HHV8-KS data are derived from small, hospital-based studies [2] , which may not be representative of the countries or regions where the studies were conducted; thus, firm conclusions cannot be made.
To gain insights into small-area variation of HHV8, we investigated HHV8 seroepidemiology in Uganda, where national KS incidence is relatively well described [9] . We used a large, nationally representative population-based sample. [10, 11] were retrieved for this study. The UHSBS was a weighted, nationally representative population-based sample of people from Uganda. Uganda's 56 districts were grouped into 9 geographic regions, of which 8 consisted of 5-8 neighboring districts and 1 region consisted of 1 district, Kampala, which is also the capital city of Uganda. The UHSBS was designed to be statistically adequate to provide robust estimates for key HIV-AIDS indicators nationally and regionally. Participants were selected using a 2-stage nonstratified cluster sample survey design. The first stage involved randomly selecting 417 census enumeration areas (primary sampling units) from the enumeration area list constructed for the Uganda National Census of 2002 [12] . In the second stage, 25 households were randomly selected from each enumeration area for a total of 10,437 households [10, 11] . Household members aged 15-59 years were invited to answer structured precoded intervieweradministered household and individual questionnaires about their age, sex, residence, religion, marital status, attained level of formal education, current occupation, and household assets. A venous blood sample was drawn from participants who consented to perform tests for HIV, syphilis, HSV2, and HBV serology, which were completed using standard commercial assays [10] , and for storage for future tests.
METHODS

Data and archival plasma samples from the Uganda human immunodeficiency virus (HIV)-AIDS serobehavioral survey (UHSBS) conducted in 2004-2005
For the current study, we randomly selected 3097 (17.8%) of 19,656 participants in the UHSBS cohort, of whom 2705 were tested serologically for anti-HHV8 antibodies. We excluded from this study participants who only had filter paper dry bloodspot samples ( ), whose samples were exhausted n p 81 ( ), who refused to be tested in future studies ( ), n p 3 n p 2 and those whose samples could not be found in the repository in Uganda ( ). n p 306 The Uganda National Council of Science and Technology provided ethical permission to conduct the Uganda HIV-AIDS serobehavioral survey. Ethical permission to test for human herpesvirus 8 antibodies was given by the Uganda Virus Research Institute, the Centers for Disease Control, and Prevention, and by the Office of Human Subject Research at the National Institutes of Health.
HHV8 serological testing. Anti-HHV8 antibodies were assayed at the Uganda Virus Research Institute HIV Reference laboratory (Entebbe, Uganda) with use of enzyme immunoassays based on synthetic peptides encoded by K8.1 and orf65 viral genes. Peptides were manufactured at the Centers for Disease Control and Prevention herpes virology laboratory [13, 14] and were sent to Uganda immediately before testing. Blank uncoated wells were run as negative controls for each plasma specimen, to provide background optical density readings. HHV8 test sample optical density readings were adjusted by subtracting the optical density reading of the negative well from the test sample optical density readings. Samples were considered to be HHV8 positive when the adjusted optical density values were 10.7 on the K8.1 test or 12.5 on the orf65 test for samples with optical density results of 0.5-0.7 on the K8.1 test. Samples that did not meet these criteria were considered to be HHV8 negative. Prior to testing study samples in Uganda, feasibility for large-scale HHV8 testing in Uganda was assessed by parallel testing a panel of 162 well-characterized samples (subjects with KS, asymptomatic Ugandans, and HIV-positive and -negative white persons) at the Centers for Disease Control and Prevention and at Uganda Virus Research Institute (Spearman's rank correlation coefficient for optical density values, 0.86 for K8.1 and 0.78 for orf65;
, for both). P ! .001 Statistical methods. HHV8 seropositivity patterns were assessed by calculating weighted HHV8 seropositivity for male and female persons separately, as well as combined using the SURVEYFREQ procedure in SAS, version 9.2 (SAS Institute), to account for the survey design. Standard errors and confidence intervals (CIs) for associations of HHV8 seropositivity with geographic region and demographic variables were estimated using the Rao-Scott x 2 statistic [15] . Odds ratios and 95% CIs of association of HHV8 seropositivity with geographic region and demographic variables were estimated using PROC SURVEYLOGISTIC. The change in HHV8 seropositivity for each single year of age was expressed as a percentage change in the odds ratio for each year of age and was also tested for statistical interaction between HHV8 seropositivity, sex, and age group (!40 years vs у40 years) in a model specifying age group, sex, and an age group-sex interaction term. We also graphically explored change in HHV8 seropositivity across 5 age groups, because HHV8 seropositivity among male and female persons crossed over at 40 years of age. Independent association of HHV8 seropositivity with geographic region and demographic variables was assessed in multivariable models that included variables with established associations with HHV8 seropositivity and those that were significant with a P value !.05 in the SURVEYFREQ 2-way table analysis. Variables that became nonsignificant in the multivariable model were dropped from the final model, except if they were postulated a priori (eg, geographic region) or were considered to be confounders (eg, formal education). Hypothesis testing was based on the Wald test, and 2-sided P values !.05 were considered to be statistically significant.
RESULTS
The weighted national rate of HHV8 seropositivity was 55.4% (95% CI, 53.0%-57.8%) and was slightly higher among male than among female persons (57.5% vs 53.7%; ) (Table P p .054 1). No differences were noted with regard to sex ( ) and P p .80 age group ( ) among persons who were excluded P p .20 ( ) versus those who were included ( ), but HIV n p 416 n p 2681 infection prevalence was higher among those who were excluded than those who were included (15.7% vs 5.7%; P ! ) (data not shown). .001
Among male persons, HHV8 seropositivity was stable among those aged 15-19 years to 40-49 years (54.2%-56.4%) and increased steeply to 71.9% among those aged 50-59 years ( , for trend) ( Table 1) . No difference was noted in P p .022 HHV8 seropositivity among those residing in urban and rural areas, but seropositivity differed among men residing in different geographic regions. HHV8 seropositivity was lowest among men from the East Central region (43.6%) and highest among those from the Western and West Nile regions (63.9% and 64.5%, respectively; , for heterogeneity). HHV8 P p .005 seropositivity was unrelated to marital status, religion, wealth index, occupational group, and HIV seropositivity, but it was inversely related to attained level of formal education (P p ). .020
Among female persons, HHV8 seropositivity increased from 45.5% among those aged 15-19 years to 60.3% among those aged 40-49 years and increased to 80.6% among female persons aged 50-59 years ( , for trend) ( Table 1 ). HHV8 sero-P ! .001 positivity was lower among women from urban areas than among those from rural areas (45.0% vs 55.2;
). Sim-P p .005 ilar to findings among men, HHV8 seropositivity differed among women residing in different geographic regions. HHV8 seropositivity was lowest among women from Kampala (39.1%) and highest among women from the Western and West Nile regions (58.0% and 67.0%, respectively;
, for hetero-P p .039 geneity). In contrast to findings among men, HHV8 seropositivity among women differed by marital status ( , for P p .001 heterogeneity). Similar to findings in men, HHV8 seropositivity was unrelated to religion, wealth index, occupational group, or HIV seropositivity, but it was inversely associated with attained level of formal education ( ). P p .004 Among participants aged !40 years, HHV8 seropositivity was higher among men than women. Conversely, among those aged у40 years, it was higher among women than men (Figure 1 ). In a model including sex, age group, and an interaction term for sex and age group, HHV8 seropositivity showed significant statistical interaction with age group and sex ( , for P p .034 heterogeneity). In stratified multivariable models, HHV8 seropositivity increased 1.2% per year of adult age (95% CI, 1.0%-2.3%) among men, was significantly different by region ( ), and was marginally inversely associated with level P p .027 of attained formal education ( ) (Table 2) . Among P p .062 women, HHV8 seropositivity increased 2.2% per year of adult age (95% CI, 1.0%-3.6%) but was not independently different by geographic region ( ) or by level of attained formal P p .101 education (
). In multivariable models combining men P p .224 and women to gain statistical stability, HHV8 seropositivity was lower among women than men (adjusted odds ratio, 0.82 [95% CI, 0.69-0.97]), was inversely associated with attained level of formal education ( ), and varied by geographic region P ! .01 ( , for heterogeneity). Specifically, HHV8 seropositivity P p .021 was higher in the West Nile than Central region (adjusted odds ratio, 1.49 [95% CI, 1.02-2.18]) but was not different in the other 8 regions (Table 2 ).
DISCUSSION
We found moderate but significant regional variation in HHV8 seropositivity, which has not been noted in Uganda before. We also found significant association of HHV8 seropositivity with male sex, older age, and lower level of attained education, and we found a significant statistical interaction of HHV8 seropositivity with age group and sex. Our findings suggest that factors correlated with small-area geography, sex, age, and formal education may influence risk of HHV8 infection.
The geographic pattern of HHV8 seropositivity resembled the pattern of standardized KS morbidity in Uganda before the AIDS epidemic (Figure 2 ) [9] . Ecological comparisons of HHV8 and KS regional distributions are risky because HHV8 seropositivity and KS data are derived from noncontemporaneous time periods, and KS data are probably not accurate. Both conditions, however, were coincidentally highest in the West Nile and Western regions of Uganda and were lower elsewhere. Notable differences were also apparent. HHV8 seropositivity varied 1.5-fold from the lowest to the highest prevalence region, whereas standardized KS incidence varied 3-6-fold from the lowest to the highest region [9] . This HHV8-KS disparity suggests that geographic cofactors may influence risk for HHV8 seropositivity separately from the risk for KS, given HHV8 infection. In contrast to KS, which has had a dramatically increase in prevalence in Uganda during the AIDS epidemic, on the basis of data from Kampala region [16] , HHV8 seropositivity was unrelated to HIV seropositivity in our study. Similar findings have been reported in some [17, 18] but not all studies [19] [20] [21] [22] . The pattern of HHV8 seropositivity does not resemble the HIV pattern in Uganda (ie, HIV seropositivity is high in Kampala and low in the West Nile region) [10, 11] , which suggests that our HHV8 seropositivity patterns are more comparable to KS patterns in the pre-AIDS era.
Geographic cofactors, including soil types [4] , exposure to plants [5] , and behaviors, such as transferring HHV8 in saliva to denuded surfaces when saliva is used to soothe itchy insect bite wounds [6] , have been postulated, but most remain untested in individual-level studies [23] . Our finding of higher HHV8 seropositivity in the West Nile region reinforces the notion that geographic cofactors may influence risk of HHV8 infection and/or KS. Interestingly, the small-area variation we observed is reminiscent of the modest but significant positive association we found between HHV8 seropositivity and low village elevation in Tanzania [24] . The West Nile region differs from other regions in Uganda in lying at the center of the Congo-Nile river basin, where climate is favorable for colonization and dispersion of diverse vectors for helminth parasites, such as snails for schistosomal parasites and simulium flies for filarial worms [25] . This ecologic niche, coupled with traditional economic activity, such as fishing, subsistence farming, and gathering firewood, places humans in direct regular contact with numerous parasites. Given that chronic exposure to helminth parasites is associated with immune perturbations [26] , we speculate that this small-area variation in HHV8 seropositivity and KS, similar to HHV8 variation in Tanzania [24] , may be a surrogate for biological effects of parasites that influence HHV8 spread and/or progression to KS. Interestingly, intestinal helminths have been associated with KS [27, 28] and schistosomal infection with HHV8 seropositivity [29] , lending some support to the hypothesis that parasites may influence HHV8 and/or KS risk.
Our finding of an age-related increase in HHV8 seropositivity agrees with some [24, 30] but not all studies [18, 20] . This finding is interpreted as an epidemiologic clue to ongoing lowgrade HHV8 transmission, possibly, via sexual contact, although this is controversial in Africa [31] . HHV8 infection is thought to spread mostly via person-to-person contact with saliva during childhood [32, 33] . Our finding of higher HHV8 seropositivity among older women, compared with men, in Uganda contrasts with findings in Tanzania [24] . The Tanzanian study was designed to investigate intrafamilial HHV8 patterns, and HHV8 seropositivity was higher among older men, compared with women, and women with seropositive husbands were more likely to be seropositive, suggesting that sexual transmission was possible. Perhaps women are infected by children who are shedding HHV8 virions in their saliva [32, 33] , to whom they are exposed culturally through sharing of mothering responsibilities. Alternatively, older women may be more prone than older men to lytic HHV8 infection [8] , which could also explain our findings. The HHV8 seropositivity disparity in by sex, although significant, is substantially less in magnitude than the disparity of endemic and epidemic KS by sex (M:F ratio, 10:1 and 3:1, respectively) [16] . Disparities between HHV8 and KS by sex and geography suggest that cofactors may influence risk for HHV8 infection and for KS separately or through different mechanisms. Our study has some limitations. HHV8 serology is imperfect [34] ; thus, HHV8 seropositivity could have been misclassified. Misclassification of HHV8 seropositivity, however, would be random and would bias the results toward the null. The strengths of our study include being a large, nationally representative population-based sample with detailed demographic data from all regions in Uganda. This allowed us to explore small-area geographic HHV8 patterns. Our study demonstrated a model for international collaboration and feasibility of technology transfer to Africa for large-scale HHV8 serology testing.
To summarize, HHV8 seropositivity showed significant variation by geography, age, and sex and was inversely related to level of attained formal education. Our findings point to an interplay of factors correlated with geography, sex, and age in HHV8 infection and KS risk.
